Dimerix Limited (ASX:DXB)
Australia · Delayed Price · Currency is AUD 0.2400
-0.1500 (-38.46%)
Apr 28, 2026, 4:17 PM AEST
Dimerix Market Cap
Dimerix has a market cap or net worth of 144.1 million as of April 28, 2026. Its market cap has decreased by -31.29% in one year.
Market Cap
144.10M
Enterprise Value
105.64M
Revenue
7.42M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.24
Market Cap Chart
Since July 6, 2015, Dimerix's market cap has increased from 13.24M to 144.10M, an increase of 988.63%. That is a compound annual growth rate of 24.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 144.10M | -56.36% |
| Dec 31, 2025 | 330.22M | 74.10% |
| Dec 31, 2024 | 189.67M | 117.15% |
| Dec 29, 2023 | 87.35M | 87.74% |
| Dec 30, 2022 | 46.53M | -40.82% |
| Dec 31, 2021 | 78.61M | 69.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Racura Oncology | 517.08M |
| Clinuvel Pharmaceuticals | 455.87M |
| Starpharma Holdings | 303.23M |
| Tetratherix | 240.12M |
| Orthocell | 236.04M |
| Actinogen Medical | 158.03M |
| Recce Pharmaceuticals | 153.27M |
| Island Pharmaceuticals | 110.84M |